Efficacy and safety of statin and fibrate combination therapy in lipid management

Autor: Epari Sanjeeva Rao, Lalit Kumar Meher, Kirtikumar D Modi, Sruti Jammula, Sunil Kumar Kota
Rok vydání: 2012
Předmět:
Zdroj: Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 6:173-174
ISSN: 1871-4021
DOI: 10.1016/j.dsx.2012.09.009
Popis: Adequate control of hyperlipidemia is of paramount importance for prevention of vascular events. Statins and fibrates are well established treatments for hyperlipidemia. Combination therapy with a statin and fibrate offers significant therapeutic advantage for the treatment of severe or refractory mixed hyperlipidemia. Although such a combination does increase the risk of myopathy, with an incidence of approximately 0.12%, this small risk of myopathy rarely outweighs the established morbidity and mortality benefits of achieving lipid goals. Nevertheless, a higher incidence of myopathy has been reported with statin monotherapy. Statin + fibrate therapy should be considered if monotherapy or adding other drugs (e.g. cholesterol absorption inhibitors, omega-3 fatty acids or nicotinic acid) did not achieve lipid targets or is impractical. The current article focuses on recent studies highlighting the beneficial effects of this combination.
Databáze: OpenAIRE